Key terms

About INSP

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest INSP news

Today 2:02am ET Buy Rating Affirmed for Inspire Medical Systems Amid Robust Overseas Sales and Upbeat Full-Year Guidance Today 1:38am ET Inspire Medical Systems: Strong Growth and Positive Outlook Justify a Buy Rating May 08 12:01pm ET Inspire Medical falls -34.4% May 08 10:01am ET Inspire Medical falls -28.9% May 08 9:48am ET Inspire Medical falls -25.5% May 08 9:39am ET Lululemon initiated, Block upgraded: Wall Street’s top analyst calls May 08 8:39am ET Inspire Medical price target lowered to $203 from $205 at Leerink May 08 7:35am ET Inspire Medical downgraded to Neutral from Buy at BofA May 08 7:04am ET Inspire Medical price target raised to $255 from $250 at Piper Sandler May 07 4:26pm ET Inspire Medical sees FY24 EPS 10c-20c, consensus (36c) May 07 4:23pm ET Inspire Medical reports Q1 EPS (34c), consensus (65c) May 07 4:13pm ET Inspire Medical Systems Engages with Investors in Upcoming Meetings Apr 22 1:51am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (INSP) and AdaptHealth (AHCO) Apr 19 7:50am ET Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) Apr 19 4:43am ET Inspire Medical initiated with an Outperform at RBC Capital Apr 18 9:00am ET Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Inspire Medical Systems (INSP) and Maravai Lifesciences Holdings (MRVI) Apr 18 8:24am ET UBS remains bullish on Inspire Medical after Lilly’s OSA results Apr 18 7:30am ET Analysts’ Top Healthcare Picks: Inspire Medical Systems (INSP), Eli Lilly & Co (LLY) Apr 18 5:57am ET Inspire Medical Systems: Assessing the Impact of Tirzepatide on Implant Sales and Maintaining a Hold Rating Apr 17 12:00pm ET Inspire Medical rises 7.8% Apr 17 10:39am ET Inspire rises, ResMed slips as Street digests data from Lilly sleep apnea trials Apr 17 9:47am ET Inspire Medical rises 6.0% Apr 17 9:25am ET Positive SURMOUNT-OSA Trial Results Reinforce Buy Rating for Inspire Medical Systems Apr 17 9:15am ET KeyBanc views Lilly’s SURMOUNT-OSA results as ‘a bit of a relief’ for Inspire Apr 17 9:14am ET Lilly OSA results ‘small net-positive’ for Inspire Medical, says Morgan Stanley Apr 17 9:11am ET JPMorgan says Lilly data positive for Inspire Medical, buy shares Apr 17 8:55am ET ResMed, Inspire Medical slip after Lilly sleep apnea trials meet goal Apr 16 6:55am ET Inspire Medical Systems (INSP) was downgraded to a Hold Rating at Stifel Nicolaus Mar 22 7:40am ET Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE) Mar 22 5:18am ET Wells Fargo Releases a Hold Rating on Inspire Medical Systems (INSP) Mar 21 2:20am ET Leerink Partners Remains a Hold on Inspire Medical Systems (INSP)

INSP Financials

1-year income & revenue

Key terms

INSP Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

INSP Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms